Patel Sanjiv — SEC Form 4 filings
SEC reporting owner CIK 1816210. 16 Form 4 filings on record with FilingPulse; latest filed 2026-09-09.
Transaction summary — filings shown
Covers all 16 filings on record, filed 2024-01-18 to 2026-09-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 17 legs across 11 filings — 1,149,851 shares, $7,881,965 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: sale of 48,199 shares @ $20.33 ($979,886) in Relay Therapeutics, Inc., filed 2026-08-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Relay Therapeutics, Inc. (RLAY) | President and CEO, Director | 16 | — | 17 legs · 1,149,851 sh · $7,881,965 | 12 |
Form 4 filings — Patel Sanjiv
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-09 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 48,199 @ $18.94 | EDGAR |
| 2026-08-18 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 48,199 @ $20.33 | EDGAR |
| 2026-07-08 | 4 | Relay Therapeutics, Inc. (RLAY) | Grant/award (A): 3,056 @ $6.95 · Sale (S): 48,199 @ $19.58 | EDGAR |
| 2026-01-15 | 4 | Relay Therapeutics, Inc. (RLAY) | Grant/award (A): 1,450,000 (derivative) @ $0 | EDGAR |
| 2026-01-07 | 4 | Relay Therapeutics, Inc. (RLAY) | Grant/award (A): 994 @ $2.99 · Sale (S): 43,168 @ $7.82 | EDGAR |
| 2025-11-04 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 62,073 @ $7 | EDGAR |
| 2025-07-10 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 42,740 @ $3.57 · Sale (S): 18,639 @ $3.57 | EDGAR |
| 2025-07-01 | 4 | Relay Therapeutics, Inc. (RLAY) | Grant/award (A): 5,000 @ $2.94 | EDGAR |
| 2025-04-24 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 42,769 @ $2.97 · Sale (S): 18,653 @ $2.97 | EDGAR |
| 2025-02-13 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 140,182 @ $3.85 · Grant/award (A): 332,465 @ $0 · Sale (S): 75,324 @ $3.70 | EDGAR |
| 2025-01-23 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 125,000 @ $4.52 · Sale (S): 125,000 @ $4.80 · Sale (S): 125,000 @ $4.78 | EDGAR |
| 2025-01-14 | 4 | Relay Therapeutics, Inc. (RLAY) | Grant/award (A): 1,105,000 (derivative) @ $0 | EDGAR |
| 2024-12-18 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 100,000 @ $5 | EDGAR |
| 2024-07-29 | 4 | Relay Therapeutics, Inc. (RLAY) | Option exercise (M): 50,000 @ $5.04 · Sale (S): 50,000 @ $9.16 · Option exercise (M): 36,706 @ $5.04 · Sale (S): 36,706 @ $9.07 · Option exercise (M): 50,000 (derivative) @ $0 · Option exercise (M): 36,706 (derivative) @ $0 | EDGAR |
| 2024-07-01 | 4 | Relay Therapeutics, Inc. (RLAY) | Grant/award (A): 2,108 @ $5.54 | EDGAR |
| 2024-01-18 | 4 | Relay Therapeutics, Inc. (RLAY) | Grant/award (A): 762,360 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1816210 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →